Charles Raison, MD

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA · Full program

• CourseIntegrative Psychiatry Intensive: Systems-Level Biology and Lifestyle Factors Transforming Psychiatric Practice

  September 15, 2026

  Half-day ticketed intensive covering four integrative domains — temperature-based interventions, rapid sleep-optimization strategies, nutritional psychiatry, and metabolic regulation of brain function — framed as complements to standard psychopharmacology.

  GLP-1 & Metabolic PsychiatryLifestyle & Integrative PsychiatrySleep & Insomnia

• DebatePsychedelic Therapy After the Executive Order: Now What?

  September 15, 2026

  Opening-afternoon multidisciplinary panel pairing a patient's lived-experience story with a policy update on how the recent executive order and existing regulatory frameworks may shape near-term clinical use of psychedelic therapies.

  Practice, Policy & WorkforcePsychedelics

• SymposiumMasterClass: Unlocking the Doors of Depression: Neuroplastic and Psychedelic Therapies in MDD

  September 17, 2026

  Examines glutamatergic and serotonergic neuroplasticity pathways and the evidence base for investigational psychedelic and psychedelic-assisted therapies in major depression.

  DepressionNeuroscience & MechanismsPsychedelics

• SymposiumPsychedelics in Psychiatry: Where the Evidence Stands Today and What Comes Next

  September 18, 2026

  Evidence-focused update on psychedelic-assisted therapy trials, regulatory developments, and safety considerations, emphasizing separation of validated data from public enthusiasm.

  Drug Pipeline & Clinical TrialsPsychedelics

• LectureInflammatory and Immune-Driven Depression: CRP, Biomarkers, and Anti-Inflammatory Treatment Pathways

  September 19, 2026

  Reviews the inflammatory depression phenotype and CRP-guided antidepressant selection, plus anti-inflammatory, glutamatergic, microbiome, and lifestyle interventions targeting immune activity.

  DepressionInflammation & ImmunopsychiatryLifestyle & Integrative PsychiatryPharmacogenomics & Precision Psychiatry

• PlenaryCultivating Clinical Wisdom in Deprescribing - Practical Considerations for Psychiatry

  September 19, 2026

  Closing session on when and how to reduce psychotropic regimens: identifying candidates, shared decision-making, and safe tapering while weighing relapse and withdrawal risks.

  Deprescribing & Polypharmacy